Merger Notification - Announcement according to § 10 Cartel Act

Catalent Pharma Solutions, Inc.; Bristol-Myers Squibb S.r.l. - BWB/Z-4480 | Bundeswettbewerbsbehörde

Catalent Pharma Solutions, Inc.; Bristol-Myers Squibb S.r.l.

BWB/Z-4480

26.06.2019

On 25.06.2019 the Austrian Federal Competition Authority was notified of the following merger:

Planned purchase process

Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 23.07.2019.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 24.07.2019 .

back to list